Immune cell binding nanoparticle could lead to new sepsis treatment
A nanoparticle that binds to immune cells in the body has been shown to tune down inflammation and offer a potential first-of-a-kind treatment for sepsis.
Archives for October 26, 2015
Quintiles to access patient data for Phase IV studies through IMS Health deal
Quintiles has formed an alliance with information and technology provider IMS Health to access real-world drug data to be used in post-approval clinical research.
Russia's clinical trial approvals 'on the increase'
The number of clinical trials given the green light in Russia has increased 13% in the third quarter of the year, which could be thanks in part to a reduction in red tape.
Explosion-hit GSK plant loses GMP certificate
A GlaxoSmithKline plant in China that was hit by an explosion in the summer has had its Good Manufacturing Practice (GMP) certificate revoked by the UK medicines regulator.
Novartis joint venture helps virtual trial CRO to $6.5m fundraising round
Science 37 has raised $6.5m (€5.7m) from Lux Capital and dRx Capital, the fund set up by Novartis and Qualcomm, to advance its virtual clinical trial service business.